Technical Analysis for EVGN - Evogene
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.67 | 1.49% | 0.01 |
Earnings due: May 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Gapped Up | Strength | 1.49% | |
| Oversold Stochastic | Weakness | 1.49% | |
| Stochastic Buy Signal | Bullish | 2.98% | |
| NR7 | Range Contraction | 2.98% |
| Alert | Time |
|---|---|
| Possible NR7 | about 15 hours ago |
| Possible Inside Day | about 15 hours ago |
| 10 DMA Resistance | about 16 hours ago |
| 60 Minute Opening Range Breakout | about 18 hours ago |
| Up 2% | about 18 hours ago |
Get a Trading Assistant
- Earnings date: 05/07/2024
Evogene Description
Evogene Ltd., a plant genomics company, engages in the development of enhanced plant traits through the use of plant genomics. It primarily focuses on the development of food crops, including corn, soybean, cotton, canola, rice, and wheat, as well as castor for the production of biofuel. The company's technologies include ATHLETE for gene discovery; Gene2Product for enhancing trait efficacy and probability of successful development of biotechnology seed products; and EvoBreed for breeding enhancement. It holds granted or pending patents to approximately 3,000 novel genes. The company has collaboration agreements with Bayer CropScience; Biogemma; Centre de Cooperation Internationale en Recherche Agronomique pour le Development; DuPont; Monsanto Company; Rahan Meristem (1998) LTD; Rasi Seeds (P) Ltd.; Syngenta; Vilmorin; Viterra; and Zeraim Gedera for the development of various products and provision of plant enhancement solutions. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Genomics Wheat Crops Soybean Biofuel Cotton Canola Oil Rehovot Monsanto Seed Products
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.44 |
| 52 Week Low | 0.4502 |
| Average Volume | 176,169 |
| 200-Day Moving Average | 0.77 |
| 50-Day Moving Average | 0.79 |
| 20-Day Moving Average | 0.72 |
| 10-Day Moving Average | 0.68 |
| Average True Range | 0.05 |
| RSI (14) | 40.12 |
| ADX | 17.37 |
| +DI | 15.10 |
| -DI | 21.04 |
| Chandelier Exit (Long, 3 ATRs) | 0.71 |
| Chandelier Exit (Short, 3 ATRs) | 0.76 |
| Upper Bollinger Bands | 0.83 |
| Lower Bollinger Band | 0.61 |
| Percent B (%b) | 0.26 |
| BandWidth | 29.72 |
| MACD Line | -0.04 |
| MACD Signal Line | -0.04 |
| MACD Histogram | -0.0057 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.70 | ||||
| Resistance 3 (R3) | 0.70 | 0.69 | 0.69 | ||
| Resistance 2 (R2) | 0.69 | 0.68 | 0.69 | 0.69 | |
| Resistance 1 (R1) | 0.68 | 0.68 | 0.68 | 0.68 | 0.69 |
| Pivot Point | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 |
| Support 1 (S1) | 0.66 | 0.66 | 0.67 | 0.66 | 0.65 |
| Support 2 (S2) | 0.65 | 0.66 | 0.65 | 0.65 | |
| Support 3 (S3) | 0.64 | 0.65 | 0.65 | ||
| Support 4 (S4) | 0.64 |
